Revisão Acesso aberto Revisado por pares

Historical epidemiology of hepatitis C virus ( HCV ) in select countries – volume 3

2015; Wiley; Volume: 22; Issue: S4 Linguagem: Inglês

10.1111/jvh.12475

ISSN

1365-2893

Autores

Valentina Liakina, Saeed Hamid, Junko Tanaka, Sigurður Ólafsson, Ala I. Sharara, Seyed Moayed Alavian, Liana Gheorghe, Ehsan Hassan, Faisal Abaalkhail, Zaigham Abbas, Ahmed Ms Abdou, A. Abourached, F. Al Braiki, Farida Al Hosani, K. Al Jaberi, Maryam Al Khatry, Mariam Al Mulla, Huda Al Quraishi, A. Al Rifai, Y. Al Serkal, Altaf Alam, Hamad I. Al‐Ashgar, Sameer Alawadhi, L. Al‐Dabal, Pauls Aldiņš, Faleh Z. Al-Faleh, Abdullah Alghamdi, Raafat F. Alhakeem, Abdulrahman Aljumah, A. Almessabi, Adel Alqutub, Khalid Alswat, I. Altraif, Mohammed Al Za’abi, N. Andrea, Abdullah M. Assiri, Mohammed A. Babatin, Agha Wajdan Baqir, Maha T Barakat, Ottar M. Bergmann, Abdul Rahman Bizri, Sarah Blach, Asad Chaudhry, Moon Seok Choi, T. Diab, Samsuridjal Djauzi, Salem Khoury, Chris Estes, Samir M. Fakhry, Javed Iqbal Farooqi, H. Fridjonsdottir, Rino Alvani Gani, Aamir Khan, Adrian Goldiș, Magnús Gottfreðsson, S. Gregorčič, Behzad Hajarizadeh, Kwang‐Hyub Han, Irsan Hasan, A. Hashim, Gábor Horváth, B Hunyady, Rola Husni, Wasim Jafri, Agita Jēruma, Jón G. Jónasson, B. Karlsdottir, Do Young Kim, Y. S. Kim, Zaher Koutoubi, Laurentius A. Lesmana, Young‐Suk Lim, Arthur Löve, Matti Maimets, Michael Makara, Reza Malekzadeh, Mojca Matičič, Muhammad Sadik Memon, Shahin Merat, Jacques Mokhbat, Fadi H. Mourad, David Handojo Muljono, Arif Nawaz, N. Nugrahini, S. Priohutomo, H Qureshi, P. Rassam, Homie Razavi, Devin Razavi‐Shearer, Kathryn Razavi‐Shearer, Baiba Rozentāle, M. Sadik, Khwaja Mir Islam Saeed, Amjad Salamat, R. Salupere, Faisal M. Sanai, A. Sulaiman, Raymond Sayegh, Jonathan Schmelzer, Anjali Sibley, M. Siddiq, A. M. Siddiqui, G. Sigmundsdóttir, Bryndís Sigurðardóttir, Danutė Speičienė, A. Sulaiman, M. A. Sultan, M. Taha, H. Tarifi, Ghias Un Nabi Tayyab, Ieva Tolmane, M. Ud din, Muhammad Umar, Jonas Valantinas, J. Videčnik‐Zorman, César Yaghi, Evy Yunihastuti, Muhammed Aasim Yusuf, Bader Faiyaz Zuberi, J. Gunter,

Tópico(s)

Hepatitis B Virus Studies

Resumo

Summary Detailed, country‐specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus ( HCV ) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Iran and Lebanon to 4.2% in Pakistan. The largest viraemic populations were in Pakistan (7 001 000 cases) and Indonesia (3 187 000 cases). Injection drug use ( IDU ) and a historically unsafe blood supply were major risk factors in most countries. Diagnosis, treatment and liver transplant rates varied widely between countries. However, comparison across countries was difficult as the number of cases changes over time. Access to reliable data on measures such as these is critical for the development of future strategies to manage the disease burden.

Referência(s)